Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 229 | nsp3:E229Q; | CL-3e; |
| 268 | nsp3:E268-; | CL-3e; |
| 268 | nsp3:E268D; | CL-3e; |
| 29 | nsp3:E29-; | CL-3b; |
| 29 | nsp3:E29A; | CL-3e; |
| 29 | nsp3:E29D; | CL-3b; |
| 29 | nsp3:E29G; | CL-2; |
| 29 | nsp3:E29K; | CL-3e; |
| 308 | nsp3:E308D; | CL-3b;CL-3c; |
| 308 | nsp3:E308G; | CL-3f; |
| 318 | nsp3:E318-; | CL-3b;CL-3e; |
| 318 | nsp3:E318A; | CL-2; |
| 318 | nsp3:E318K; | CL-3d; |
| 324 | nsp3:E324-; | CL-3e;CL-3f; |
| 324 | nsp3:E324G; | CL-3b; |
| 374 | nsp3:E374A; | CL-3e; |
| 374 | nsp3:E374D; | CL-3c; |
| 374 | nsp3:E374K; | CL-3d;CL-3e;CL-3f; |
| 374 | nsp3:E374V; | CL-3e; |
| 378 | nsp3:E378V; | CL-3e; |
| 37 | nsp3:E37D; | CL-3e; |
| 37 | nsp3:E37G; | CL-3e; |
| 37 | nsp3:E37Q; | CL-3d; |
| 382 | nsp3:E382-; | CL-3e; |
| 382 | nsp3:E382A; | CL-3c; |
| 382 | nsp3:E382G; | CL-3b;CL-3d; |
| 382 | nsp3:E382K; | CL-1b;CL-3c; |
| 387 | nsp3:E387-; | CL-3f; |
| 387 | nsp3:E387G; | CL-3e;CL-3f; |
| 391 | nsp3:E391D; | CL-3b;CL-3d; |
| 391 | nsp3:E391G; | CL-3e; |
| 392 | nsp3:E392-; | CL-3d;CL-3e;CL-3f; |
| 392 | nsp3:E392D; | CL-3e;CL-3f; |
| 392 | nsp3:E392G; | CL-3d; |
| 399 | nsp3:E399-; | CL-3b; |
| 399 | nsp3:E399A; | CL-3e; |
| 399 | nsp3:E399K; | CL-3b; |
| 405 | nsp3:E405A; | CL-1b; |
| 405 | nsp3:E405G; | CL-3e; |
| 419 | nsp3:E419G; | CL-3f; |
| 419 | nsp3:E419K; | CL-3e; |
| 426 | nsp3:E426A; | CL-3e; |
| 426 | nsp3:E426G; | CL-3c; |
| 426 | nsp3:E426K; | CL-3d; |
| 427 | nsp3:E427-; | CL-3e;CL-3f; |
| 427 | nsp3:E427G; | CL-3e; |
| 433 | nsp3:E433-; | CL-3e; |
| 433 | nsp3:E433K; | CL-3b; |
| 433 | nsp3:E433L; | CL-2; |
| 475 | nsp3:E475-; | CL-1b; |
Page 262 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com